#$%^&*AU2017200015A120170202.pdf#####ABSTRACT EFFICIENT SYSTEMIC TREATMENT OF DYSTROPHIC PATHOLOGIES 5 A composition comprising a gene therapy product for use in the treatment of a dystrophic disease in a subject, advantageously in humans, wherein: - the gene therapy product comprises a nucleic acid sequence encoding a functional microdystrophin - the composition is systemically administered. 10